Using the eSexual Health Clinic to access chlamydia treatment and care via the internet: a qualitative interview study. by Aicken, Catherine RH et al.
1Aicken CRH, et al. Sex Transm Infect 2017;0:1–7. doi:10.1136/sextrans-2017-053227
AbstrAct
Objective We developed the eSexual Health Clinic 
(eSHC), an innovative, complex clinical and public health 
intervention, embedded within a specialist sexual health 
service. Patients with genital chlamydia access their 
results online and are offered medical management 
via an automated online clinical consultation, leading 
to antibiotic collection from community pharmacy. A 
telephone helpline, staffed by Sexual Health Advisers, 
is available to support patients and direct them to 
conventional services if appropriate. We sought to 
understand how patients used this ehealth intervention.
Methods Within exploratory studies of the eSHC 
(2014–2015), we conducted in-depth interviews with 
a purposive sample of 36 patients diagnosed with 
chlamydia, who had chosen to use the eSHC (age 18–35, 
20 female, 16 male). Thematic analysis was conducted.
results Participants described choosing to use this 
ehealth intervention to obtain treatment rapidly, 
conveniently and privately, within busy lifestyles that 
hindered clinic access. They described completing the 
online consultation promptly, discreetly and with ease. The 
information provided online was considered comprehensive, 
reassuring and helpful, but some overlooked it in their 
haste to obtain treatment. Participants generally described 
being able to collect treatment from pharmacies discreetly 
and promptly, but for some, poor awareness of the eSHC 
by pharmacy staff undermined their ability to do this. Those 
unsuitable for remote management, who were directed 
to clinic, described frustration and concern about health 
implications and clinic attendance. However, the helpline 
was a highly valued source of information, assistance and 
support.
conclusion The eSHC is a promising adjunct to 
traditional care. Its users have high expectations 
for convenience, speed and privacy, which may be 
compromised when transitioning from online to face-
to-face elements of the eSHC. Managing expectations 
and improving implementation of the pharmacy process, 
could improve their experiences. Positive views on the 
helpline provide further support for embedding this 
ehealth intervention within a specialist clinical service.
IntrOductIOn
STI rates remain high in England, despite existing 
STI control measures.1 2 Prompt effective treatment 
of diagnosed STIs is vital to reduce harms associated 
with long-term infection and onward transmission. 
However, timely access to genitourinary medicine 
(GUM) clinics is threatened by increasing financial 
pressures.3 4 ehealth may increase access and conve-
nience, at a potentially reduced cost.5–7 Globally, 
the push for internet-based healthcare, combined 
with the realisation that traditional models of face-
to-face physician-led care are unsustainable, has 
never been stronger, but underpinning research on 
acceptability and effectiveness is lacking.
Sexual health is a promising arena for ehealth. In 
the UK, young people, a risk-group for STI,1 have 
near-universal internet access8 and report greater 
internet-use for help/advice with their sex-lives 
than older age-groups.9 Online services may 
enhance privacy in this sensitive and stigmatised 
area.10 However, development and evaluation of 
ehealth services, as complex interventions, requires 
an understanding of the mechanisms and contexts 
in which they work,11 including a contextualised 
understanding of users’ behaviour.12
Through detailed formative research,10 13 14 
we developed an online clinical pathway for STI 
management, using genital chlamydia as an exem-
plar. This pathway was deployed within an eSexual 
Health Clinic (eSHC, figure 1),15 a web-applica-
tion, which people logged into to access their STI 
test results. Via the eSHC web-application, people 
testing positive for chlamydia were provided with 
information and were offered the opportunity 
to follow an automated online clinical consulta-
tion, consisting of tailored questions on presence 
of symptoms, medical history, drugs and allergies, 
sexual history and a risk assessment for blood 
borne viruses.16 If safe and appropriate, this led to 
collection of treatment from a chosen community 
pharmacy. A helpline, staffed by a specialist Sexual 
Health Adviser (SHA), was available throughout 
and facilitated access to clinic/general practice (GP) 
for those for whom ‘remote’ management (away 
from clinical services and medical professionals) 
was inappropriate. All users were followed up 
by telephone by an SHA, to check treatment was 
taken correctly, ascertain partner notification (PN) 
outcomes and provide support if needed.
The eSHC is unique within the National Health 
Service (NHS), in enabling users to receive a new 
medical diagnosis online and (if safe, appropriate 
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and desired) proceed to treatment, ‘remote’ from medical settings 
and with minimal supervision. The few existing NHS online STI 
services enable access to testing,17 18 but treatment of those testing 
positive requires individualised assessment by a clinician,16 in 
healthcare settings or by telephone.
We piloted the eSHC in exploratory studies.15 Within these, we 
conducted qualitative research among people who had tested posi-
tive for chlamydia (the focus of this article) to understand the expe-
rience of using this internet-based intervention, in order to inform 
its refinement and future evaluation.
MetHOds
setting and population
This qualitative study took place among participants of the explor-
atory studies who had tested positive for genital chlamydia. These 
studies’ methods are detailed elsewhere.15 Briefly, people who had 
tested in two GUM services or via South London internet-based 
postal home-sampling (‘Checkurself ’, within the National Chla-
mydia Screening Programme, NCSP) received their chlamydia-pos-
itive result online and were offered the opportunity to use the 
eSHC (figure 1). Those coinfected with another STI or extragenital 
chlamydia, aged under 16, unable to read English or not providing 
a mobile phone number, were ineligible and managed as per stan-
dard care.
Interview recruitment and sampling
During the eSHC’s follow-up phone-call, SHAs asked patients 
with adequate spoken English for permission to pass their 
first name and mobile number to a researcher, to discuss a 
possible telephone interview.
Sampling was purposive,19 with quotas of 6–12 women and 
men in age-group (16–24, ≥25 years) and testing service (clinic 
or ‘Checkurself ’) categories (total: eight categories). Additional 
sampling categories, developed during data collection, captured 
diversity in eSHC use (which was unknown a priori).
data collection
One female interviewer (CA) conducted in-depth interviews by 
telephone, with oral informed consent. She introduced herself 
as a non-clinical researcher, interested in understanding what 
it is like to use the eSHC. Interviews took place on average 5 
Figure 1 The eSHC. This figure was published in The Lancet Public Health, 2017;2(4):182–90, Estcourt et al, ‘The eSexual Health Clinic system for 
management, prevention and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia trachomatis.’, Elsevier 
2017. Notes: Only those testing chlamydia positive were included in the current study. Those testing negative were not interviewed and we do not 
report data on the small number of people who participated as notified sexual partners of chlamydia-positive study participants. Health information 
was available on results screen and via links to reputable websites. Patients who reported, in the online consultation, symptoms indicative of 
potentially complex infection or allergies, an underlying medical condition or that they were on medication which meant that they needed an 
alternative antibiotic, were alerted to telephone the helpline to facilitate access to traditional care. The Sexual Health Adviser staffing the helpline was 
simultaneously alerted to telephone the patient, in case they did not make contact. All those consenting to participation in the Exploratory Studies 
were followed up (top of figure). eSHC, eSexual Health Clinic; SMS, short messaging system (text message).
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days after completion of eSHC follow-up, using a topic guide 
informed by previous research10 13 (see online supplementary 
file 1). Participants were offered a £30 e-voucher as reimburse-
ment. Data collection ceased when sampling quotas were full 
and no new findings were emerging.
data management and analysis
Transcripts of audio-recordings (average: 44 min) were checked 
to ensure accuracy and anonymity.
We conducted a thematic analysis,20 using Framework21 for 
data management, in which data are organised into matrices 
by participant and descriptive code. Codes were based on 
elements of the eSHC (figure 1) and topics identified in previous 
research.10 Two researchers double-coded a selection of tran-
scripts and agreed with the codes (CA and LS, in discussion with 
MS). CA coded transcripts in NVivo and then identified four 
emergent themes describing how participants used the eSHC 
from these ordered data. Themes were refined in discussion with 
LS and MS and applied to the data in a second phase of coding.
Ethical approval was granted by Brighton & Sussex (NHS) 
Research Ethics Committee (ref:13/LO/1111).
results
Sixty-two per cent (87/140) of the eligible patients agreed to 
be contacted, of which the interviewer attempted to contact 58 
and interviewed 40 (69%i, including four partners of chlamyd-
ia-positive eSHC users, data not reported). Table 1 describes this 
study’s 36 participants.
themes describing use of the esexual Health clinic
1: Do something, fast!
Participants assumed that the eSHC would facilitate rapid treat-
ment, which influenced their choice to proceed online following 
their chlamydia diagnosis. As this participant explained:
i Related to telephone recruitment, where phone calls sometimes were 
unanswered, reasons for non-participation were often unknown.
table 1 Sample characteristics, reported behaviours and experiences
Gender* Women Men total
demographics
  Age (years)* 18–24 10 8 18
25–35 10 8 18
  Ethnicity† Asian 1 2 3
Black 2 5 7
Mixed 3 1 4
White 14 8 22
  Relationship status† Single 7 9 16
In relationship 8 3 11
Split up with partner, related to chlamydia diagnosis 4 0 4
Casual partner/s 1 3 4
Not discussed 0 1 1
  Sexual orientation† Heterosexual, straight 18 16 34
Not discussed (but recent partners opposite sex) 2 0 2
experience of sexual healthcare
  Previous STI testing† Yes 16 12 28
No 3 4 7
Not discussed 1 0 1
  Previous STI diagnosis† Yes 7 5 12
Not had chlamydia before 1 0 1
No 12 11 25
  Testing (this episode)* In a sexual health (GUM) clinic 12 8 20
Via internet-based postal home-sampling (NCSP Checkurself) 8 8 16
esexual Health clinic use
  Route to treatment* Directed to clinic/GP 6 1 7
Disengaged from eSHC and treated in clinic 2 1 3
Completed to pharmacy treatment collection 12 14 26
of which: Problems with treatment collection: 2+ trips to 
pharmacy and/or helpline use 3 1 4
No problems at pharmacy or problems resolved 
during one visit without helpline 9 13 22
  Helpline use Yes, self-initiated 6 0 6
Yes, when prompted, re: being directed to clinic 3 1 4
No 11 15 26
total 20 16 36
*Primary sampling characteristics.
†Secondary sampling characteristics, by which we sought diversity across the entire sample.
GUM, genitourinary medicine; NCSP, National Chlamydia Screening Programme.
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[the website] gives you the options, you know, go and see someone 
or go online. And I thought, well actually, y’know, if I wanna get 
treated now… (26-year-old man, tested via Checkurself)
This urge to act quickly following receipt of their chlamydia 
diagnosis led to some participants to proceed immediately online 
using their smartphones. They described how this enabled rapid 
completion of the online consultation, while maintaining privacy 
(discussed below, theme 2), even in public locations:
I wanted to get it sorted straight away[…] And mobile’s quite 
discreet[…] I thought for all everyone around me knows I was just 
on facebook. (29-year-old man, tested in clinic, completed online 
consultation at his desk in a shared office)
For others, feelings of urgency were balanced with privacy 
concerns and technology constraints (themes 2 and 3). Thus, 
some completed the online consultation later the same day they 
received their results and changed location and/or device.
[During my lunch-break] I just tried to find some privacy and to go 
and check the information again on the laptop first, because, well 
I had more time, and you have a bigger screen so it’s just easier to 
read. So I really read all the information which was included in the 
results and, yeah, after, I answered the questions and ordered the 
medication online. (26-year-old man, tested in clinic)
Participants typically described the information provided 
online as helpful and comprehensive. However, some of those 
who felt panic and rushed through the consultation on their 
smartphones while in public, considered the information inad-
equate and mentioned missing details which were actually 
present. As this man, who described lacking information about 
what chlamydia is, explained:
Maybe it did say that but I was too busy frantically trying to [laughs] 
get to the antibiotic stage. (29-year-old man, tested in clinic)
In contrast, using the eSHC’s web-interface at relaxed pace, in 
greater privacy (theme 2) appeared to result in greater uptake or 
recall of the information provided.
Participants described the process of completing the online 
clinical consultation and selecting (online) a pharmacy from 
which to collect treatment, as quick and easy. Treatment collec-
tion from pharmacies generally worked well, preserving partic-
ipants’ desire for prompt treatment access and comparing 
favourably with their experiences of clinic. Describing the 
process as ‘seamless’, this man explained that pharmacy staff:
…seemed to know exactly what I was here for and I said I was part 
of an eSTI trial, grabbed some medicine, and I was out within about 
five minutes. (22-year-old, tested in clinic)
However, in some cases, pharmacy staff were apparently 
unaware of the study or could not locate treatment packs, such 
that participants needed to return to the pharmacy on another 
occasion. This led to a short delay for participants (a few days), 
but had a significant impact on their experience, in the context 
of having an STI requiring treatment:
… it just seemed like the longest wait ever and I was quite frustrated 
at the time, quite upset. (26-year-old woman, tested in clinic)
Participants generally described taking treatment the day 
they collected it (and with a good understanding of information 
received in treatment-packs and online.)
2: Protecting privacy
All participants described acting to conceal their STI and treat-
ment-seeking from those around them, but to varying extents. 
Some, particularly Checkurself users, sought to avoid the embar-
rassment and exposure that they associated with sexual health 
clinic attendance. For them, the eSHC was:
…definitely a much more, sort of less embarrassing way to go about 
it, without, y’know, having to worry about seeing anyone you know 
[in clinic]. (20-year-old woman, tested via Checkurself)
When completing the online consultation, some protected 
their privacy by using their smartphone, while others changed 
location (as discussed, theme 1). Participants described providing 
information via the online consultation with ease and some 
considered it a more private way of providing sexual history 
details, with:
…no one there to give you their opinions straight away, or even kind 
of make a gesture that would suggest their opinion. You can be as 
honest as possible, I think. You can be more honest than if you go to 
a clinic. (27-year-old man, tested in clinic)
While some participants mentioned concerns about online 
data security, they appeared to accept this as an inevitable part of 
the online experience:
…on the internet, it’s just that fear of maybe someone else is going 
to get the information. [Interviewer: Was that a concern for you?] 
No, no, er- no, actually cos I do a lot of things on the internet, 
so I actually trust the internet. A lot. (22-year-old man, tested via 
Checkurself)
However, privacy was sometimes threatened during transi-
tions from online, to offline, public space. For instance, when 
the pharmacy treatment collection process worked as intended, 
participants could maintain discretion about their reason for 
attending the pharmacy, but when pharmacy staff were unaware 
of the study, participants’ attempts to explain their needs in this 
public setting were perceived to compromise privacy:
…three or four people sat about a metre behind me[…] I don’t 
think [staff] clicked that it was something I didn’t really want to 
be shouting about. [They said:] ‘No I don’t get– I don’t know what 
you’re on about!’ Erm, just shhh… (24-year-old woman, tested via 
Checkurself)
3: Choices and non-choices
Positive perceptions of the eSHC as a fast, private way to obtain 
treatment influenced participants’ choice to use it (themes 1 
and 2). In addition, they described how this choice was influ-
enced or constrained by difficulties (re)attending conventional 
services, in the context of busy lifestyles.
[To attend clinic] I have to either book an appointment, which is 
also not gonna be easy cos of my working hours, or get there really, 
really early[…] when I saw it, an online option to do it, I thought 
this is much— probably gonna be much easier. (27-year-old man, 
tested in clinic)
Certain constraints also influenced how participants used the 
intervention. For instance, although all described completing the 
online consultation the day they received their results (theme 1), 
some delayed collecting treatment because they were away from 
home (a constraint which also hindered their access to conven-
tional services via which they could obtain treatment, such as 
sexual health clinics or general practice).
Problems that some participants experienced with pharmacy 
treatment collection were exacerbated when participants faced 
difficulties reattending:
…they were asking me to come back another day and I was like, 
I can’t do that[…] I already leave work earlier to make sure I can 
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get my treatment, and like they won’t allow me like to leave earlier 
every day… (27-year-old woman, tested in clinic)
4: Seeking peace of mind
Following diagnosis, the prospect of a quick, discreet and conve-
nient route to treatment via the eSHC (as discussed, themes 1–3) 
was reassuring, as was the eSHC’s basis in NHS services, which 
conferred trustworthiness:
…I knew that the [home sampling-]kit was from the NHS. I, I just 
trusted everything that came with it, so I trusted the text, the link, 
and my results. I also trusted the treatment. (21-year-old woman, 
tested via Checkurself)
To resolve concerns about their chlamydia infection, its 
treatment and implications, participants sought information 
online, some used the helpline and two described contacting 
other services (eg, GP). In the interviews, participants typically 
discussed how it is ‘definitely’ necessary to have a helpline avail-
able. However, while they were using the eSHC, some had not 
noticed that a helpline was provided when they were using the 
eSHC (despite the number being displayed on each page of the 
eSHC web-application; they commented that they probably had 
not noticed or looked for it, because they had not needed it 
themselves). Helpline users described using it for information, 
technical assistance and/or support:
I probably knew what to do, but it’s just because I was a bit 
overwhelmed about everything. I thought I need to speak to 
someone… (32-year-old woman, tested via Checkurself)
Those who sought support described the helpline particularly 
positively:
…it’s always nice to have someone to kind of look after you and 
make sure that everything is fine. (26-year-old woman, tested in 
clinic)
Similarly, participants appreciated the ‘closure’ and ‘personal 
touch’ (29-year-old man, tested in clinic) of the follow-up 
phone-call:
…if no one called me, then I would’ve felt a bit like, ‘well, is it done, 
what should I do?’ (22-year-old woman, tested via Checkurself)
Alternative experiences
We used alternative experiences described by participants to 
refine themes and to illustrate further how they interrelate.22
Being directed to clinic for treatment
As an integral part of the eSHC, patients whose online consulta-
tion responses indicated that ‘remote’ provision of Azithromycin 
was inappropriate were instructed to call the helpline and could 
not continue online. By telephone, the SHA emphasised the 
importance of attending clinic, offered to book an appointment 
and provided information.
Those who had disclosed symptoms online described annoy-
ance and anxiety about their health and about attending clinic—
which, by choosing the eSHC, many had sought to avoid (see 
themes 1–3). For instance, this woman felt ‘really upset’, because 
she ‘thought it would be a bit embarrassing to go to the clinic’:
… also because it said [online], ‘because you said that you’ve got 
one of the symptoms you need to come,’ so I was like, I hope it 
doesn’t mean it’s going to be more complicated… (22-year-old, 
tested via Checkurself)
Helpline contact, informing participants of the precautionary 
nature of this visit, was reassuring (theme 4). However, some 
remained unconvinced that clinic attendance had been necessary.
Abandoning the eSHC
Two participants received their diagnosis online, but abandoned 
the eSHC and attended clinic. Both described being particu-
larly upset about the impact of their diagnosis on relationships 
(and one, on her health). Contrasting with the busy schedules 
discussed by others, both described having the flexibility to 
attend clinic the day they received their results (themes 1, 3) and 
sought reassurance through human contact (theme 4).
I felt more relieved, like, talking to someone[…] even though I knew, 
you know, I had all the information[…] I was looking for a bit of 
comfort. (34-year-old woman, tested in clinic)
dIscussIOn
This is the first qualitative study describing the experience of 
using a novel online sexual health intervention, which enabled 
some users to proceed from receipt of results to treatment 
collection without seeing or speaking to a clinician.15 Gener-
ally, the eSHC enabled patients to receive chlamydia treatment 
promptly and discreetly, within busy lifestyles. They provided 
sensitive information online easily and without embarrassment, 
yet valued the helpline’s availability. Greatest satisfaction was 
expressed by those who obtained treatment from community 
pharmacies without problems, for whom the perceived benefits 
of online care were preserved ‘offline’. However, these benefits 
were sometimes compromised when transitioning from online, 
to offline/public spaces: among the minority15 directed to clinic 
for treatment or at pharmacy treatment collection.
The eSHC provides an alternative management option for 
patients with uncomplicated chlamydia and was embedded 
within a specialist service, providing safeguards, specialist health 
professional support and follow-up, and facilitated clinic access. 
Positive views about the eSHC helpline (staffed by sexual health 
clinic SHAs) support the eSHC’s basis in specialist services. 
Patients’ expectations of a rapid, discreet and convenient service 
must be borne in mind during refinement of ‘offline’ parts of the 
eSHC. Clarification that not everyone will be medically appro-
priate for online management may better manage expectations.
Awareness and uptake of online health information appeared 
to be influenced by context. Where users were calm and their 
surroundings private, they found the information comprehen-
sive and reassuring. Our study highlights the impact of some 
users’ feelings of anxiety and urgency of treatment-seeking, on 
uptake of online health information following diagnosis of an 
acute, stigmatised condition. The potential loss of ‘teachable 
moments’23 that this precipitates may apply to future inter-
net-based sexual health services, eg, for emergency horomonal 
contraception, or HIV self-testing. Despite evidence of effec-
tiveness of some internet-based sexual health promotion inter-
ventions,24 these have not yet been studied within online care 
pathways. Further research is needed to explore ways to improve 
uptake of online health promotion, for those testing positive or 
negative, including consideration of ehealth literacy.
Despite participants being recently diagnosed with an STI, 
thus potentially difficult to research, we achieved a strong, 
diverse sample, qualitatively representing those who had tested 
in clinic and via internet-based home-sampling and those with/
without experience of STI treatment, whose perspectives may 
differ. However, men who have sex with men (MSM) were 
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unrepresented; very few participated in the exploratory studies 
(people with coinfection and extragenital chlamydia, both more 
common among MSM, were excluded).
All participants chose the eSHC, so our findings do not extend 
to everyone with chlamydia (or other STIs). Those with lower 
health literacy or digital literacy may be unable or unwilling to 
use ehealth.25 Patients were offered the eSHC after using estab-
lished NHS testing services, which enhanced their confidence in 
using it.
Interviewing shortly after completion of care helped mini-
mise recall issues. Telephone interviewing was appropriate to 
the sensitive topic and participants’ choice of ‘remote’ health-
care, but those who declined participation may have had higher 
requirements for privacy and convenience.
There is a dearth of similar studies. As e-prescribing is typi-
cally physician-mediated, studies of patients’ experience of this 
have limited relevance to the eSHC, while research on commer-
cial online pharmacies’/vendors’ treatment provision focuses on 
quality and legality.26–28 Our findings extend and complement 
our previous research, which explored the acceptability of a 
hypothetical STI self-test and online care, in a younger popu-
lation.10 Some differences (eg, lower concerns about online 
data security) may reflect the current study population’s older 
age-range and experience of internet-based healthcare.
This study informs the eSHC’s refinement for future evalu-
ation. Mixed-methods analysis of the eSHC’s support for PN 
is underway. Future qualitative research must explore the views 
of non-users of the eSHC and MSM. Mindful of concerns that 
ehealth could widen health inequalities,29 30 evaluation must 
include assessment of the educational and socioeconomic status 
of users and non-users.
Key messages
 ► The eSexual Health Clinic is unique in supporting patients 
from online receipt of a new chlamydia diagnosis, to 
treatment, remotely and with minimal supervision.
 ► Building on formative research, we used qualitative 
interviews to generate a contextualised description of 
patients’ experience of using this novel ehealth intervention.
 ► Patients described obtaining treatment rapidly and discreetly 
online compared with attending a clinic, but valued optional 
access to specialist sexual healthcare professionals by 
telephone, for reassurance, assistance and information.
 ► Refinement to ‘offline’ parts of this ehealth intervention, to 
preserve privacy, convenience and speed of treatment, may 
further increase its acceptability.
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